Lavastre Valérie, Chiasson Sonia, Cavalli Hélène, Girard Denis
Institut National de Recherche Scientifique, INRS-Institut Armand-Frappier, Pointe-Claire, Canada.
Leuk Res. 2005 Dec;29(12):1443-53. doi: 10.1016/j.leukres.2005.05.014. Epub 2005 Oct 19.
Viscum album agglutinin-I (VAA-I) is a potent inducer of cell apoptosis and possesses anti-tumoral activity. Using PLB-985 and chronic granulomatous disease (X-CGD) cells, which lack expression of gp91(phox), VAA-I was found to induce apoptosis in both cell lines as assessed by cytology, DNA laddering and degradation of the cytoskeletal protein gelsolin. Both cell lines expressed caspase-3 and -8 and VAA-I activated these caspases. We demonstrated that lamin B(1) is a novel target to VAA-I and its degradation was reversed by a pan-caspase inhibitor and by a caspase-6, but not a caspase-8, inhibitor.
欧洲槲寄生凝集素-I(VAA-I)是一种强效的细胞凋亡诱导剂,具有抗肿瘤活性。利用缺乏gp91(phox)表达的PLB-985细胞和慢性肉芽肿病(X-CGD)细胞,通过细胞学、DNA梯状条带分析和细胞骨架蛋白凝溶胶蛋白的降解评估发现,VAA-I可诱导这两种细胞系发生凋亡。这两种细胞系均表达半胱天冬酶-3和-8,且VAA-I可激活这些半胱天冬酶。我们证明核纤层蛋白B(1)是VAA-I的一个新靶点,其降解可被泛半胱天冬酶抑制剂和半胱天冬酶-6抑制剂(而非半胱天冬酶-8抑制剂)逆转。